Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement
Journal of Pharmacy Practice
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Litonjua, M. R.
Right arrow Articles by Daubert, G. P.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Digoxin: The Monarch of Cardiac Toxicities

M. Regina Litonjua, MD

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

Stephanie Penton, MD

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

Craig Robinson, MD

Detroit Receiving Hospital, Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan

G. Patrick Daubert, MD

Department of Emergency Medicine & Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, gpat-md{at}med.wayne.edu

The cardiac steroids (or glycosides) are a heterogeneous group of compounds that have been well recognized for both their clinical benefit and inherent toxicity. This review will primarily focus on digoxin because of its widespread clinical use, although the other cardiac steroids will be discussed in less detail. The cardiac steroids have a narrow therapeutic index and remain a significant source of toxicity, with nearly 5000 human exposures reported to the American Association of Poison Control Centers in 2002. Digoxin reversibly binds to the {alpha} subunit of the Na+-K+ ATPase pump and completely inhibits its enzymatic and transport functions. The cumulative effect on cardiac tissue is dependent on the number of Na+-K+ATPase pump sites that are occupied by cardiac steroid molecules. It is important to recall the pharmacokinetics of digoxin in that serum digoxin levels drawn prior to tissue distribution (<6 hours) do not accurately reflect acute toxicity. Signs and symptoms of toxicity vary between acute and chronic intoxications. A systematic approach guided by clinical symptoms with early administration of immunotherapy can lead to a significant reduction of morbidity and mortality in digoxin-poisoned patients.

Key Words: Digoxin • cardiac • toxicity • electrocardiogram • immunotherapy

References

  • Mann J. Murder, Magic, and Medicine. Oxford, England: Oxford University Press; 1992.
  • Historic Figures, William Withering (1741 - 1799). Available at: www.bbc.co.uk/history/historic_figures/withering_william.shtml. Accessed June 9, 2004.
  • Smith TW. Pharmacokinetics, bioavailability, and serum levels of cardiac steroids. J Am Coll Cardiol. 1985;2:43A-50A.
  • Mycek M, Harvey R, Champe P. Pharmocology. Philadelphia, Pa: Lippencott-Raven; 1997.
  • Rosen MR. Cellular electrophysiology of digitalis toxicity. J Am Coll Cardiol. 1985;2:22A-34A.
  • Tintinalli J, Kelen G, Stapczynski J. Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill; 2004.
  • Smith TW. Digitalis: mechanisms of action and clinical use. N Engl J Med. 1988;318:358-365.[Medline] [Order article via Infotrieve]
  • Haynes BE, Bessen HA, Wightman WD, et al. Oleander tea: herbal draught of death. Ann Emerg Med. 1985;14:350-353.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brubacher JR, Ravikumar PR, Bania T, et al. Treatment of toad venom poisoning with digoxin-specific Fab fragments. Chest. 1996;110:1282-1288.[Abstract/Free Full Text]
  • Marx JD, Hockberger RS, Walls RM, et al, eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 5 th ed. St Louis, Mo: C.V. Mosby; 2002.
  • Goldfrank LR, Flomenbaum N, Lewin N, Howland MA, Hoffman R, Nelson L. Goldfrank’s Toxicologic Emergencies. 7th ed. New York, NY: McGraw-Hill; 2002.
  • Haynes BE, Bessen HA, Wightman WD. Oleander tea: Herbal draught of death. Ann Emerg Med. 1985;14:350.
  • Hastreiter AR, John EG, van der Horst RL. Digitalis, digitalis antibodies, digitalis-like immunoreactive substances, and sodium homeostasis: a review. Cardiovasc Disease Neonate. 1988;15:491-522.
  • Surawicz B. Factors affecting tolerance to digitalis. J Am Coll Cardiol. 1985;5:69A.
  • Leahy EG. Digoxin-quinidine interactions: current status. Ann Intern Med. 1980;93:775.
  • Marcus FI. Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol. 1985;5:82A.
  • Valdes R Jr. Endogenous digoxin-like immunoreactive factors and potential implications. Clin Chem. 1985;31:1525.[Abstract/Free Full Text]
  • Bryson PD, ed. Cardiac glycosides. In: Comprehensive Review in Toxicology. Rockville, Md: Aspen; 1989.
  • Chuman M, LeSage J. Color vision deficiencies in two cases of digoxin toxicity. Am J Ophthalmol. 1985;100:682.[Web of Science][Medline] [Order article via Infotrieve]
  • Goldman RH, Kleiger RE, Schweizer E. The effect on myocardial 3-H digoxin of magnesium deficiency. Proc Soc Exp Biol Med. 1971;136:747.[CrossRef][Medline] [Order article via Infotrieve]
  • Nadeau RA, James TN. Antagonistic effects on the sinus node of acetylstrophanthidin and adrenergic stimulation. Circ Res. 1963;13:388.[Abstract/Free Full Text]
  • Mendez C, Aceves J, Mendez R. Inhibition of adrenergic cardiac acceleration by cardiac glycosides. J Pharmacol Exp Ther. 1961;131:191.[Abstract/Free Full Text]
  • Rosen MR, Wit AL, Hoffman BF. Electrophysiology and pharmacology of cardiac arrhythmias IV: cardiac and antiarrhythmic and toxic effects of digitalis. Am Heart J. 1975;89:391-399.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schwensen C. Ventricular tachycardia as a result of the administration of digitalis. Heart. 1922;9:199-205.[Web of Science]
  • Graves SW, Brown B, Valdes R Jr. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med. 1983;99:604-608.
  • Liendo C, Ghali J, Graves S. A new interference in some digoxin assays: anti-murine heterophilic antibodies. Clin Pharmacol Ther. 1996;60:593-598.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Critchley J, Critchley L. Digoxin toxicity in chronic renal failure: treatment by multi-dose activated charcoal intestinal dialysis. Hum Exp Toxicol. 1997;16:733-735.[Abstract/Free Full Text]
  • Bismuth C, Gaultier M, Conso F, Efthymiou ML. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6:153-162.[Web of Science][Medline] [Order article via Infotrieve]
  • Sundar S. Digoxin toxicity and electrolytes: a correlative study. Acta Cardiol. 1983;38:115-123.[Web of Science][Medline] [Order article via Infotrieve]
  • Kinley S, Buckley N. Magnesium sulfate in the treatment of ventricular arrythmias due to digoxin toxicity. J Toxicol Clin Toxicol. 1995;33:55-59.[Web of Science][Medline] [Order article via Infotrieve]
  • Bismuth C, Motte G, Conso F, Chauvin M. Acute digitoxin intoxication treated by intracardiac pacemaker: experience in sixty-eight patients. Clin Toxicol. 1977;10:443-456.[Web of Science][Medline] [Order article via Infotrieve]
  • Taboulet P, Baud F, Mismuth C, et al. Acute digitalis intoxications: is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31:261-273.[Web of Science][Medline] [Order article via Infotrieve]
  • Gibb T, Adams PC, Parnham AJ, Jennings K. Plasma digoxin: assay anomalies in Fab-treated patients. Br J Clin Pharmacol. 1983;16:445-447.[Web of Science][Medline] [Order article via Infotrieve]
  • Ordog GJ, Benaron S, Bhasin V, Wasserberger J, Balasubramanium S. Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med. 1987;16:32.[Web of Science][Medline] [Order article via Infotrieve]
  • Sullivan J. Immunotherapy in the poisoned patient. Med Toxicol. 1986;1:47-60.
  • Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin specific Fab antibody fragments: final report of a multicenter study. Circulation. 1990;81:1744-1752.[Abstract/Free Full Text]

Journal of Pharmacy Practice, Vol. 18, No. 3, 157-168 (2005)
DOI: 10.1177/0897190005276751
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Litonjua, M. R.
Right arrow Articles by Daubert, G. P.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Advertisement